
.
Early lung cancer
screening with a simple blood test, vastly improving survival outcomes in millions of high-risk individuals

>2.2 million people are diagnosed every year with lung cancer...
Most patients are diagnosed too late, at a metastatic stage, where survival chances plummet

We need to detect lung cancer MUCH earlier, when it is treatable.
... 1.8 million of those people die from the disease !
The five-year survival rate for lung cancer is just 20%...
… at late stage is 0% !
So, we set out to develop...
A new gold standard in lung cancer screening
Diagnosis in time:
As screening tool it can diagnose cancer early, before its too late
Suited for Large-Scale Screening:
Test may be implemented in screening programs to millions of people.

A 6-protein marker Lung Cancer Test Kit
It saves time for doctors.
It saves the lives of patients.
Almost NO False positives (±1%)
... lowering costs and avoiding emotional turmoil for patients
Low Cost:
Affordable, great chance that insurances will cover costs.
The world’s FIRST & ONLY mass screening test for lung cancer

Precision
- Massively increased predictability of lung cancer cases
- Highly specific to rule out disease

Survival
- Improves survival rate dramatically, from 0% (late-stage) to >85% (early-stage)
- Higher adoption rate & more survivors

Efficiency
- Shorter Treatment Timelines
- Faster results
- Fits into routine diagnostic procedures

Minimal-Invasive
- No side effects
- Low trauma
- Painless/ Minimally invasive

Care
- Convenient for Doctors/Clinics
- Opposite to standard care (LDCT), potential available at all sites
- Could be offered by any doctor

Access
- Increased access to screening
- Mobile Screening Programs enabled
- Reduced wait-times for screening
Total estimated lives saved each year if all high-risks individuals would be screened with AerionX*
1.3 Mio
Survivors
= population of Dallas/Texas or Milan/Italy
*Compared to current standard care
Contact
We are fundraising to commercialize the lung cancer kit. For more information reach out to us.
